|
業務類別
|
Biotechnology |
|
業務概覽
|
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI. |
| 公司地址
| 100 Regency Forect Drive, Suite 300, Cary, NC, USA, 27518 |
| 電話號碼
| +1 858 251-4400 |
| 傳真號碼
| +1 650 365-6490 |
| 公司網頁
| https://www.herontx.com |
| 員工數量
| 128 |
| Dr. William P. Forbes |
Executive Vice President and Chief Development Officer |
美元 592.25K |
30/04/2025 |
| Ms. Ira Duarte |
Executive Vice President and Chief Financial Officer |
美元 515.00K |
26/02/2026 |
| Mr. Craig A. Collard |
Director and Chief Executive Officer |
美元 669.50K |
26/02/2026 |
| Mr. Mark Hensley |
Chief Operating Officer |
-- |
29/04/2025 |
|
|
| Mr. Craig A. Johnson |
Independent Director |
26/02/2026 |
| Mr. Craig A. Collard |
Director and Chief Executive Officer |
26/02/2026 |
| Mr. Christian Waage |
Independent Director |
26/02/2026 |
| Mr. Michael Kaseta |
Independent Director |
26/02/2026 |
| Mr. Thomas Cusack |
Director |
26/02/2026 |
| Mr. Adam Morgan |
Chairman of the Board |
26/02/2026 |
| Dr. Sharmila Dissanaike, F.A.C.S.,M.D. |
Independent Director |
26/02/2026 |
|
|
|
|
